Rhinitis Allergic Perennial
📧 Sign up to get email alerts when something new happens for Rhinitis Allergic Perennial.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-10EMA Authorised: Desloratadine Actavis (desloratadine) — Actavis Group PTC ehf
Authorised Desloratadine Actavis (desloratadine) for allergic rhinitis and urticaria in the EU.
-
EMA approval · 2026-07-10EMA Authorised: Desloratadine ratiopharm (desloratadine) — Ratiopharm GmbH
Authorised desloratadine product from Ratiopharm (desloratadine) for allergic rhinitis and urticaria indications in the EU.
-
EMA approval · 2022-06-24EMA Authorised: Desloratadine ratiopharm (desloratadine) — Ratiopharm GmbH
Authorised desloratadine product Desloratadine ratiopharm by Ratiopharm GmbH for allergic rhinitis and urticaria indications.
-
EMA approval · 2022-06-09EMA Authorised: Dasselta (desloratadine) — Krka, d.d., Novo mesto
Dasselta (desloratadine) by Krka has been authorised for allergic rhinitis (perennial and seasonal) and urticaria in the EU.
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) [Phase 3]
Phase 3 clinical trial update validating a patient preference module (EARNS-Q) for allergic rhinitis nasal sprays; results posted after comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study. [Phase 4]
Phase 4 long-term pediatric growth study for fluticasone furoate nasal spray (Veramyst) completed; results posted in 2012.
-
EMA withdrawal · 2011-11-17EMA Application withdrawn: Desloratadine Krka (desloratadine) — Krka, d.d., Novo mesto
The EMA withdrew the application for Desloratadine Krka, desloratadine, by Krka d.d., Novo mesto.
-
EMA withdrawal · 2011-10-18EMA Lapsed: Alisade (fluticasone furoate) — Glaxo Group Ltd.
The EMA lists Alisade (fluticasone furoate) as lapsed, with withdrawal of its marketing authorization in 2010.